Dr Deme Karikios
@DKarikios
Followers
2K
Following
12K
Statuses
3K
Dad/hubby|PhD|Med onc@Nepean|USyd Senior Lecturer|Interests: GI/lung cancer|value|fin tox|Luv Rabbitohs & Dr Who| @csoncol oncologist. Opinions = mine
Sydney - Australia
Joined June 2013
Never been involved in anything more important. Outcomes that matter to patients is what we strive for. @csoncol
So our inaugural CSO paper- our manifesto- is just out with invitation to all stakeholders to join our movement. @csoncol is all about outcomes that matter to our patients, and how to ensure that our goals are aligned towards improving these outcomes. 1/
1
11
48
RT @sharonnahm: Encouraging all MOGA members to register for this interesting webinar on 'Conflicts of Interest in Medical Oncology'. (Als…
0
2
0
RT @oncology_bg: Wow, this is why we need RCTs. Patients in the experimental arm had 6 months SHORTER survival than patients in the control…
0
5
0
RT @Berninini: Check out our latest work from Common Sense Oncology! We detail essential principles for the design, analysis, and reporting…
0
2
0
RT @AOParsonson: Join us! Expressions of Interest now open for Young Oncologist Group of Australia (YOGA) Committee 2025 👩⚕️👨⚕️ The role…
0
4
0
RT @MOGA_ORG: 📢Registration is Open!📢 2025 MOGA ASM, Melbourne, 12 - 14 August. This year's theme: Beyond the Checkpoints – Navigating the…
0
2
0
RT @oncology_bg: Now Online! CSO RCT Checklist. @csoncol RCT team has just published in @TheLancetOncol a CHECKLIST to design and report c…
0
49
0
RT @oncology_bg: These last 2 months have been our milestone months. We have published some- in my opinion- really important pieces. Since…
0
11
0
RT @oncology_bg: Every time they approve a drug based on non-survival endpoint, they give us some excuse. I have collected those excuses. T…
0
56
0
RT @oncology_bg: A very meaningful global oncology study led by our very own @fabiomoraesmd and other members of @QueensGlobalOnc ! Congrat…
0
2
0
RT @oncology_bg: Please do read our letter to editor to @JCO_ASCO with regards to the recent publication of the ARANOTE trial. Until when s…
0
27
0
RT @finn_corinne: 📊 An International @EORTC Survey on Stage III NSCLC resectability: ✅ Resectable: Smaller tumors, w/ single-station N2 Lar…
0
48
0
RT @StephenVLiu: One of the forgotten costs of cancer therapy is time spent in the clinic. Report on time toxicity @JCOOP_ASCO on pts with…
0
45
0
@oncology_bg @NiuSanford @drkiwicj Have been using long course followed by FOLFOX at my site. Long course driven by the preference of our rad onc, and our surgeons like to often offer watch and wait which this allows.
0
1
2
RT @ausyoungoncs: 🚨 YOUNG ONC WORKSHOP IS HAPPENING THIS MORNING🚨 🙌🏻 Join @zarnielwin @DrMarkNalder @DrTimSlattery @BrandonBZLau for great…
0
7
0
RT @drprunellab: The crew at the annual @TOGAANZ Lung Cancer Preceptorship in Brisbane. My fave meeting of the year! 👏
0
2
0
RT @LiangRhea: A centrally coordinated, low-cost mentorship program is feasible and of high value. Fab research from @jiajennyliu and team-…
0
6
0
RT @DrChristinaTeng: Thanks @hagsie for the whirlwind status update of #OXTOX at #AGITG24: 81% recruitment and 🤩 inclusion from regional pt…
0
3
0
@DrChristinaTeng @hagsie @GICancer @ErinMoth1 @drprunellab @CraigUnderhill @janette_vardy @LChantrill Another lovely patient consenting today at Nepean too! #almostthere!
2
0
4
RT @SamuelXStevens: Thanks #WadePullin for the shout out re: time toxicity for people living with advanced cancer at #COSA24! Excited to sh…
0
3
0